Aaron G.l. Fletcher is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 16 open-market trades across 4 companies since 2019, most recently 2026-06-17.
CIK 0001789490
13 open-market purchases totalling $11.5M since 2019, against 3 sales. Across 13 scored buys the stock is up 3.0% at ninety days, and 0.8 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 62% | 38% | 46% |
| Avg Move | -0.4% | -6.9% | +3.0% |
| Alpha | -2.1% | -6.9% | -0.8% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LTRN | SELL | 2024-05-23 | 2024-05-28 | $6.31 | $277K | -9.3% | -26.2% | -24.4% |
| LTRN | SELL | 2023-11-29 | 2023-12-01 | $3.44 | $1000K | +5.9% | +11.2% | +28.3% |
| TFFP | BUY | 2022-11-22 | 2022-11-23 | $1.15 | $50K | -14.1% | -32.0% | -51.1% |
| CUE | BUY | 2022-05-23 | 2022-05-25 | $3.47 | $712K | +8.3% | -17.4% | -11.3% |
| TFFP | BUY | 2022-05-16 | 2022-05-17 | $4.91 | $538K | +20.2% | +5.1% | +15.0% |
| TFFP | BUY | 2022-04-04 | 2022-04-04 | $6.47 | $3.5M | -19.5% | -33.6% | -23.7% |
| CUE | BUY | 2022-03-31 | 2022-04-04 | $4.76 | $3.5M | -24.3% | -28.2% | -55.8% |
| CGTX | BUY | 2021-10-13 | 2021-10-15 | $12.00 | $2.3M | +0.9% | -3.9% | -46.0% |
| CGTX | SELL | 2021-10-13 | 2021-10-15 | $12.04 | $1K | +0.9% | -3.9% | -46.0% |
| TFFP | BUY | 2020-11-24 | 2020-11-24 | $15.13 | $76K | +4.0% | +2.5% | +5.2% |
| CUE | BUY | 2020-11-24 | 2020-11-25 | $12.64 | $166K | +2.4% | -2.0% | +3.2% |
| CUE | BUY | 2020-06-24 | 2020-06-25 | $24.88 | $373K | -2.7% | -16.7% | -37.4% |
| TFFP | BUY | 2020-05-26 | 2020-05-26 | $5.08 | $102K | +6.2% | +14.8% | +162.1% |
| TFFP | BUY | 2020-04-15 | 2020-04-17 | $4.72 | $26K | +14.1% | +19.6% | +49.2% |
| TFFP | BUY | 2020-04-02 | 2020-04-06 | $4.01 | $161K | -8.3% | -2.4% | +30.1% |
| TFFP | BUY | 2019-10-25 | 2019-10-29 | $5.00 | $10K | +7.4% | +4.6% | -0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.